M
Michael J. Corwin
Researcher at Boston University
Publications - 112
Citations - 7450
Michael J. Corwin is an academic researcher from Boston University. The author has contributed to research in topics: Sudden infant death syndrome & Sudden death. The author has an hindex of 43, co-authored 109 publications receiving 6986 citations. Previous affiliations of Michael J. Corwin include West Virginia University & Beth Israel Deaconess Medical Center.
Papers
More filters
Journal ArticleDOI
Efficacy and Safety of Epoetin Alfa in Critically Ill Patients
Howard L. Corwin,Andrew Gettinger,Timothy C. Fabian,Addison K. May,Ronald G. Pearl,Stephen O. Heard,Robert An,Peter J. Bowers,Paul Burton,Mark A. Klausner,Michael J. Corwin +10 more
TL;DR: The use of epoetin alfa does not reduce the incidence of red-cell transfusion among critically ill patients, but it may reduce mortality in patients with trauma and is associated with an increase in the rate of thrombotic events.
Journal ArticleDOI
Efficacy of Recombinant Human Erythropoietin in Critically Ill Patients: A Randomized Controlled Trial
Howard L. Corwin,Andrew Gettinger,Ronald G. Pearl,Mitchell P. Fink,Mitchell M. Levy,Marc J. Shapiro,Michael J. Corwin,Theodore Colton +7 more
TL;DR: In critically ill patients, weekly administration of a weekly dosing schedule of recombinant human erythropoietin (rHuEPO) reduces allogeneic RBC transfusion and increases hemoglobin.
Journal ArticleDOI
The Effect of Chronic or Intermittent Hypoxia on Cognition in Childhood: A Review of the Evidence
Joel L. Bass,Michael J. Corwin,David Gozal,Carol Moore,Hiroshi Nishida,Steven Parker,Alison Schonwald,Richard E. Wilker,Sabine Stehle,T. Bernard Kinane +9 more
TL;DR: Adverse impacts of chronic or intermittent hypoxia on development, behavior, and academic achievement have been reported in many well-designed and controlled studies in children with CHD and SDB as well as in a variety of experimental studies in adults.
Journal ArticleDOI
Cardiorespiratory events recorded on home monitors: Comparison of healthy infants with those at increased risk for SIDS.
R Ramanathan,Michael J. Corwin,Carl E. Hunt,George Lister,Larry R. Tinsley,Terry M. Baird,Jean M. Silvestri,David H. Crowell,D Hufford,Richard John Martin,Michael R. Neuman,Michael R. Neuman,Debra E. Weese-Mayer,L A Cupples,Mark Peucker,Marian Willinger,Thomas G. Keens +16 more
TL;DR: Test the hypothesis that preterm infants, siblings of infants who died of SIDS, and infants who have experienced an idiopathic, apparent life-threatening event have a greater risk of cardiorespiratory events than healthy term infants.
Journal ArticleDOI
Efficacy of recombinant human erythropoietin in the critically ill patient: a randomized, double-blind, placebo-controlled trial.
Howard L. Corwin,Andrew Gettinger,Robert M. Rodriguez,Ronald G. Pearl,K. Gubler,Christopher Enny,Theodore Colton,Michael J. Corwin +7 more
TL;DR: Whether the administration of recombinant human erythropoietin to critically ill patients in the intensive care unit (ICU) would reduce the number of red blood cell (RBC) transfusions required is investigated.